FindTrial
Sign In

Sodiumhexametaphosphate as Pulp Capping Material for Primary Teeth

Sodiumhexametaphosphate Versus MTA as Pulp Capping Material for Primary Teeth ( Randomized Clinical Trial)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06170775
Enrollment
100
Registered
2023-12-14
Start date
2023-12-20
Completion date
2025-01-20
Last updated
2023-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulp Disease, Dental

Brief summary

Sodiumhexametaphosphate will be tested as pulp capping material in comparison to MTA for primary teeth pulp therapy

Interventions

OTHERPulp therapy

Pulp capping material

DRUGSodiumhexametaphosphate

Sodiumhexametaphosphate

OTHERMTA

MTA

Sponsors

Minia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
4 Years to 10 Years
Healthy volunteers
No

Inclusion criteria

* physical healthy children * cooperative children * primary molar with deep carious lesion * absence of pain or transient momentary pain

Exclusion criteria

* Uncooperative children * children with systemic disorders * periapical lesions * sever pain

Design outcomes

Primary

MeasureTime frameDescription
Clinical successOne yearAbsence of pain, swelling and sinus tract
Radiographic successOne yearAbsence of periapical lesions, internal or external root resorption

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026